Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Diarrhoea | 2% | x | x | |
Angioedema | postmarketing | x | ||
Rash | postmarketing | x | ||
Nausea | postmarketing | x | x | |
Pruritus | postmarketing | x | ||
Muscle spasms | postmarketing | x | x | |
Asthenia | x | x | ||
Connective tissue disorder | x | x | ||
Cough | x | x | ||
Dizziness | x | x | ||
Fatigue | x | x | ||
Gastrointestinal disorder | x | x | ||
Orthostatic hypotension | x | x | ||
Mediastinal disorder | x | x | ||
Nervous system disorder | x | x | ||
Abnormal platelets | x | x | ||
Haemoglobin decreased | x | x | ||
Dizziness postural | x | x | ||
Serum creatinine increased | x | x | ||
Renal impairment | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |